Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: May 29, 2023

Drug Sales Trends for NIASPAN

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Drug Sales Revenue Trends for NIASPAN
Drug Units Sold Trends for NIASPAN

Annual Sales Revenues and Units Sold for NIASPAN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
NIASPAN ⤷  Try a Trial ⤷  Try a Trial 2019
NIASPAN ⤷  Try a Trial ⤷  Try a Trial 2018
NIASPAN ⤷  Try a Trial ⤷  Try a Trial 2017
NIASPAN ⤷  Try a Trial ⤷  Try a Trial 2016
NIASPAN ⤷  Try a Trial ⤷  Try a Trial 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.